X.T.L. Biopharmaceuticals Ltd. ADR (XTLB) Stock: Exploring a Year of Highs, Lows, and Trading Volume

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. X.T.L. Biopharmaceuticals Ltd. ADR’s current trading price is -33.26% away from its 52-week high, while its distance from the 52-week low is 344.00%. The stock’s price range over this period has fluctuated between $0.75 and $4.99. The company, operating within the financial sector, had a trading volume of approximately 0.83 million for the day, which was noticeably lower than the average daily share volume of 0.89 million over the last 3 months.

X.T.L. Biopharmaceuticals Ltd. ADR experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $4.99 on 03/25/24, while the lowest price for the same period was registered at $0.75 on 10/31/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

X.T.L. Biopharmaceuticals Ltd. ADR (XTLB) has experienced a quarterly rise of 220.19% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 18.15M.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.12, with a change in price of +2.38. Similarly, X.T.L. Biopharmaceuticals Ltd. ADR recorded 466,190 in trading volume during the last 100 days, posting a change of +250.49%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for XTLB stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

XTLB Stock Stochastic Average

Today’s raw stochastic average for X.T.L. Biopharmaceuticals Ltd. ADR over the last 50 days is 60.69%.This indicates a increase from the raw stochastic average of the past 20 days, which was 59.91%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 53.26% and 50.46%, respectively.

XTLB Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a gain of 229.67%.However, over the last six months, we can see a weaker performance of 321.41%. Over the last 30 days, the price of XTLB has fallen by 270.00%. And in the last five days, it has surged by 8.47%.

On Key

Related Posts